Table 1 Demography
Parameters | All patients (n = 215) |
|---|---|
Age (years) | 55.9 ± 13 |
Time since transplantation (years) | 9.2 (0.5-34) |
Time spent on dialysis (years) | 3 (0–26.3) |
Gender (male) (%) | 67.4 |
Type of dialysis (HD) (%) | 81.4 |
Height (m) | 1.68 ± 0.07 |
BMI (kg/m2) | 25 ± 5.8 |
Abdominal perimeter (cm) | 93.1 ± 13.1 |
Current smoker (%) | 14.9 |
Diabetes (%) | 18.6 |
Personal cardiovascular history (%) | 16,3 |
Coronaropathy (%) | 10,2 |
Stroke (%) | 6 |
Peripheral arteriopathy (%) | 3,3 |
Serum Creatinine (μmol/l) | 140.7 ± 55.3 |
eGFR (ml/min/1.73 m2) | 52 ± 22 |
Serum Cystatin C (mg/l) | 1.68 ± 0.65 |
Serum Homocystein (μmol/l) | 18.6 ± 8.2 |
CRP (mg/l) | 9,2 ± 20.6 |
Glycemia (mmol/l) | 6.2 ± 8.3 |
Cholesterol total (mmol/l) | 4.9 ± 1.1 |
HDL-cholesterol (mmol/l) | 1.35 ± 0.42 |
Calcemia (mmol/l) | 2.69 ± 0.68 |
Phosphoremia (mmol/l) | 1.16 ± 0.16 |
Magnesemia (mmol/l) | 0.70 ± 0.08 |
Parathormone (ng/l) | 129.68 ± 60.84 |
HR (bpm) | 67 ± 9.7 |
Brachial SBP (mm Hg) | 138 ± 17.1 |
Brachial DBP (mm Hg) | 77.7 ± 10.2 |
Aortic calcification (mean Kauppila score) | 2.8 (0–24) |
Treatment | Â |
ACE inhibitors/ARB (%) | 63,3 |
Beta-blockers (%) | 38,1 |
Calcium channel blockers (%) | 49,8 |
Diuretics (%) | 40,9 |
Aziathropine (%) | 8,8 |
MMF (%) | 60,5 |
Cyclosporine (%) | 12,1 |
Cyclosporine level (μg/l) | 81,7 ± 51,3 |
Tacrolimus (%) | 84,7 |
Tacrolimus level (ng/ml) | 6,4 ± 2,1 |
mTOR inhibitor | 8,4 |
mTOR level (ng/ml) | 4,4 ± 2 |
Corticosteroids (%) | 15,3 |